Clot penetration and retention by plasminogen activators promote fibrinolysis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Clot penetration and retention by plasminogen activators promote fibrinolysis

Published:2013-01 Issue:2 Volume:85 Page:216-222
ISSN:0006-2952
Container-title:Biochemical Pharmacology
language:en
Short-container-title:Biochemical Pharmacology

Author:

Marcos-Contreras O.A.,Ganguly K.,Yamamoto A.,Shlansky-Goldberg R.,Cines D.B.,Muzykantov V.R.,Murciano J.-C.

Funder

Society of Interventional Radiology Foundation

NIH

Fondo de Investigaciones Sanitarias

Comunidad Autónoma de Madrid

Publisher

Elsevier BV

Subject

Pharmacology,Biochemistry

Reference37 articles.

1. Therapy for acute high-risk pulmonary embolism: thrombolytic therapy and embolectomy;Meneveau;Curr Opin Cardiol,2010

2. Clinical predictors for fatal pulmonary embolism in 15,520 patients with venous thromboembolism: findings from the Registro Informatizado de la Enfermedad TromboEmbolica venosa (RIETE) Registry;Laporte;Circulation,2008

3. Thrombolysis compared with heparin for the initial treatment of pulmonary embolism: a meta-analysis of the randomized controlled trials;Wan;Circulation,2004

4. Thrombolysis in pulmonary embolism: a debatable indication;Goldhaber;Thromb Haemost,2001

5. Differential fibrinolytic properties of the recombinant plasminogen activator BM 06.022 in human plasma and blood clot systems in vitro;Martin;Blood Coagul Fibrinolysis,1993

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anti-stroke biologics: from recombinant proteins to stem cells and organoids;Stroke and Vascular Neurology;2024-01-29

2. Identification, characterization, and engineering of glycosylation in thrombolytics;Biotechnology Advances;2023-09

3. Rodent models of pulmonary embolism and chronic thromboembolic pulmonary hypertension;Heliyon;2022-03

4. Computer-aided engineering of staphylokinase toward enhanced affinity and selectivity for plasmin;Computational and Structural Biotechnology Journal;2022

5. Comparison of urokinase and reteplase thrombolytic treatment in patients with high‑risk pulmonary embolism;Experimental and Therapeutic Medicine;2019-10-31

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3